Back to search results

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Abroad (travel likely)Recruiting

Conditions

Vulvar Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • BCCA - Kelowna, Kelowna, British Columbia, Canada

    Contact: Study coordinator (Joni Kooy) · 250 712-3900

  • BCCA - Vancouver, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Amy Jamieson) · 604 729-1258

  • Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

    Contact: Study coordinator (Andra Nica) · 905 387-9495

  • Odette Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Lilian Gien) · 416 480-4329

  • University Health Network, Toronto, Ontario, Canada

    Contact: Study coordinator (Stephane Laframboise) · 416 946-4501

  • CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada

    Contact: Study coordinator (Annick Pina) · 514 890-8444

  • The Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Susie K.S. Lau) · 514 340-8222

  • Hotel-Dieu de Quebec, Québec, Quebec, Canada

    Contact: Study coordinator (Marie Plante) · 418 691-5392

  • CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke, Quebec, Canada

    Contact: Study coordinator (Paul Bessette) · 819 346-1110

  • Allan Blair Cancer Centre, Regina, Saskatchewan, Canada

    Contact: Study coordinator (Genevieve MacAulay Vacheresse)

  • Auckland City Hospital, Auckland, New Zealand

    Contact: Study coordinator (Lois Eva) · 649 307-4949
Study leads

  • Amy Jamieson

    Study Chair

    University of British Columbia, Vancouver, BC, Canada

  • Jessica McAlpine

    Study Chair

    BCCA-Vancouver Cancer Centre, Vancouver, BC Canada

View source on ClinicalTrials.gov(opens in a new tab)